These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 10117377)
1. Claim substantiation in the health care industry. Fergenson PE Hosp Mater Manage Q; 1992 May; 13(4):20-6. PubMed ID: 10117377 [No Abstract] [Full Text] [Related]
2. The role of the Federal Trade Commission in advertising health products and services. Daynard M J Am Coll Dent; 2004; 71(2):24-6. PubMed ID: 15347100 [TBL] [Abstract][Full Text] [Related]
3. Advertising gone too far? Quinn C Mark Health Serv; 2008; 28(4):20-3. PubMed ID: 19157035 [No Abstract] [Full Text] [Related]
4. The new drug marketing: a consumer protection perspective. Woodward D Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
5. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses. Mahinka SP; Sanzo KM Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000 [No Abstract] [Full Text] [Related]
6. FTC regulation of health care advertising: when providers deceive. Buc NL; Hofkin LA Healthspan; 1992 Oct; 9(9):3-6. PubMed ID: 10122717 [No Abstract] [Full Text] [Related]
7. Obesity--the new frontier of public health law. Mello MM; Studdert DM; Brennan TA N Engl J Med; 2006 Jun; 354(24):2601-10. PubMed ID: 16775242 [No Abstract] [Full Text] [Related]
8. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers. Reichertz PS Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712 [No Abstract] [Full Text] [Related]
9. FTC getting tough on false healthcare advertising. Perry L Mod Healthc; 1990 Oct; 20(41):39. PubMed ID: 10107222 [No Abstract] [Full Text] [Related]
10. Avoiding the legal pitfalls of testimonials and endorsements. Garay EB; Rutkin AS J Healthc Risk Manag; 1997; 17(1):7-12. PubMed ID: 10167186 [No Abstract] [Full Text] [Related]
11. Regulation of health services advertising. Barney DR Hosp Health Serv Adm; 1983; 28(3):85-110. PubMed ID: 10299216 [No Abstract] [Full Text] [Related]
12. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet. Reichertz PS Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029 [No Abstract] [Full Text] [Related]
13. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
14. Healthcare advertising: what you can and cannot say. Barney DR Healthspan; 1985 Jan; 2(1):3-10. PubMed ID: 10271480 [No Abstract] [Full Text] [Related]
15. Legal guidelines to health services marketing: issues & checklists. Berning RK J Health Care Mark; 1983; 3(2):47-9. PubMed ID: 10261799 [No Abstract] [Full Text] [Related]
16. The role of direct-to-consumer advertising. Navarro RP Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419 [No Abstract] [Full Text] [Related]
17. Deception in advertising and marketing: ethical applications in rehabilitation. Banja JD Arch Phys Med Rehabil; 1994 Sep; 75(9):1015-8. PubMed ID: 8085923 [TBL] [Abstract][Full Text] [Related]
18. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine. Allen MC Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553 [No Abstract] [Full Text] [Related]
19. Marketing health care products on the Internet: a proposal for updated federal regulations. Green K Am J Law Med; 1998; 24(2-3):365-86. PubMed ID: 9702278 [No Abstract] [Full Text] [Related]
20. Major issues in marketing regulation. Pines WL Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028 [No Abstract] [Full Text] [Related] [Next] [New Search]